Irish hospital activity up 6% in 2001:
This article was originally published in Clinica
Ireland's hospital activity rose by around 6% in the year to the end of December 2001. 920,000 patients were released from hospital that year, leaving the total number waiting for hospital treatment at 26,126. Day-case throughput increased by 13%. The increased activity saw a 14% fall in the average wait in target specialties. Cardiac surgery was almost halved; ear, nose and throat waits fell by 22%; gynaecology, vascular surgery and orthopaedics cut waiting times by 17, 12 and 6%, respectively. The figures were released last week, coinciding with nationwide industrial action by the nursing community, which is urging the government to increase spending on the country's under-equipped and overstretched accident and emergency services (see this issue).
You may also be interested in...
China's centralized procurement scheme, if further expanded after causing the prices of 32 drugs to be cut by more than half in the latest round, will leave companies no room to breathe easy amid the already devastating coronavirus outbreak, analysts say.
Sangamo licensed Biogen zinc finger protein transcription factor candidates in an alliance worth over $2bn. Exercising an option it gained in 2017, Takeda bought celiac disease-focused PvP Biologics for up to $330m in earn-outs. A strong showing of IPOs prompted biopharma financing to increase from last month.
With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.